We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
25 Jun 2026 - 27 Jun 2026
02 Jul 2026 - 04 Jul 2026

Ambulatory Infusion System Advances Patient Safety

By HospiMedica International staff writers
Posted on 22 Oct 2020
A novel electronic ambulatory infusion pump offers customizable protocols and pump programs for the alternate care market. More...


The Zyno Solutions (Zyno; Natick, MA, USA) Nimbus II Flex ambulatory infusion pump is intended for subcutaneous, percutaneous, perineural, epidural, and intravenous use, including patient-controlled analgesia (PCA) in clinical and other environments, such as the home. A simple-to-use intuitive design facilitates repeated ambulatory continuous low volume infusion protocols, such as in cancer chemotherapy, while the electronically controlled linear peristaltic pump provides delivery rates of 0.1mL/h to 135 mL/h at a maximum infusion pressure of 30 psi, with fluid delivery accuracy of +/- 5%.

Weighing just 174 grams, the Nimbus II Flex features several on-board pre-loaded ambulatory protocols based on hours and run time. Integrated software and hardware safeguards help prevent programming errors. A range of alarms provide added safety, including cassette loading errors, firmware and system errors, upstream and downstream occlusion alarms, unattended alarm errors, and power warnings. The Nimbus Flex II is powered via a micro-USB port, or by an internal non-rechargeable battery that provides up to 240 hours of battery life or 1,500 mL of volume infused.

“Zyno Solutions is a leader in providing IV infusion technology and is dedicated to delivering intelligent infusion systems that provide the highest quality of care and patient safety,” said the company in a press statement. “Zyno Solutions offers technologically advanced products for the alternate care market and provides large volume infusion pumps, ambulatory infusion pumps, integrated wireless infusion systems and IV accessories.”

Infusion pumps, used to infuse fluids, medications, and nutrients to the patient’s circulatory system, are used in situations where continuous monitoring and treatment by a nurse or other health staff would be expensive, impractical, or unreliable. In addition, they can be used for home-based ambulatory support, where they are used to administer a variety of therapies, including analgesics, narcotics, chemotherapy, and antibiotic or antiviral infusions.

Related Links:
Zyno Solutions


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Glucose Meter
StatStrip®
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.